54 related articles for article (PubMed ID: 20621249)
1. Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?
Hopkins KA; Bakris GL
Cardiol Clin; 2010 Aug; 28(3):447-52. PubMed ID: 20621249
[TBL] [Abstract][Full Text] [Related]
2. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
3. The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.
Godley PJ; Maue SK; Farrelly EW; Frech F
Am J Manag Care; 2005 Apr; 11(4):206-10. PubMed ID: 15839181
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
[TBL] [Abstract][Full Text] [Related]
5. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
6. [Success of blood pressure reduction in diabetic patients].
Schernthaner G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
8. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
Kadoglou NP; Iliadis F; Angelopoulou N; Sailer N; Fotiadis G; Voliotis K; Vitta I; Liapis CD; Alevizos M
J Diabetes Complications; 2009; 23(3):160-6. PubMed ID: 18413173
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular manifestations of insulin resistance.
Chahwala V; Arora R
Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of cardiovascular high risk population in specialist ambulatory care: ESA].
Zizka J; Soucek M
Vnitr Lek; 2010 May; 56(5):376-81. PubMed ID: 20578586
[TBL] [Abstract][Full Text] [Related]
13. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
15. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
[TBL] [Abstract][Full Text] [Related]
18. Nutritional management of cardiovascular risk factors. A randomized clinical trial.
McCarron DA; Oparil S; Chait A; Haynes RB; Kris-Etherton P; Stern JS; Resnick LM; Clark S; Morris CD; Hatton DC; Metz JA; McMahon M; Holcomb S; Snyder GW; Pi-Sunyer FX
Arch Intern Med; 1997 Jan; 157(2):169-77. PubMed ID: 9009974
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
Goldberg RB
Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
[TBL] [Abstract][Full Text] [Related]
20. Assessment and management of hypertension in patients with type 2 diabetes.
Thomas MC; Atkins R
Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
